Blogs

Dr. Salvador Albalat Tells Us About Wearable Technology Available to Everyone to Improve Health

Published

4 years ago

02/23/2021

Kossi Adzo

We talked to Dr. Salvador Albalat of Witooth Dental about wearable technology to improve health, and this is what he had to say:-

Table of Contents

First of all, how are you and your family doing in these times of COVID-19?

Dr. Salvador Albalat: Well, we have had difficult times due to the complexity of the pandemic. In general, good, although there are many people who are having a bad time.

Tell us about yourself, your career, how you founded Witooth Dental.

Dr. Salvador Albalat: I founded the company 4 years ago. I consider myself a multi-entrepreneur. It is the fourth company that I undertake in the health sector.

How does Witooth Dental innovate?

Dr. Salvador Albalat: Innovation is a constant in our company. We have several patents, some of them approved in the USA and EU. To date, we have obtained research grants from official organizations, in addition to our own investment.

How is the coronavirus pandemic affecting your business, and how are you dealing with it?

Dr. Salvador Albalat: The coronavirus has delayed our project since we need to measure many physiological values such as Glucose in patients with diabetes who are limited in terms of mobility due to the risk involved. On the other hand, our device will also allow us to measure the state of patients with the coronary disease if we get enough resources to adapt the AI software to our wearable.

Did you have to make tough decisions, and what are the lessons learned?

Dr. Salvador Albalat: We have had to prioritize both human and financial resources due to the closure in March.

What specific management skills, software, and tools are you using to deal with this crisis?

Dr. Salvador Albalat: To date, we have not had to use any specific resource. Regarding the management, if it has been necessary to adopt teleworking to the development of our products.

Who are your competitors? And how do you plan to stay in the game?

Dr. Salvador Albalat: Our competition is basically pharmaceutical companies and emerging companies in the digital health sector.

Your final thoughts?

Dr. Salvador Albalat: I believe that the pandemic has made us all reflect on the vulnerability of our comfort space and, at the same time, has made it possible to bring the most advanced part of our environment closer to emerging countries.